Dr. Kenneth J. Friedman, discusses the physiological aspects of ME/CFS and why it makes those afflicted feel the way they do.
Dr. Kenneth J. Friedman, discusses what is known about the causes of the disease which afflicts over 28 million people around the world.
Dr. Kenneth J. Friedman, discusses the development of biomarkers for ME/CFS. Particularly, brain imaging, bio-chemistry and exercise Testing.
Dr. Kenneth J. Friedman, discusses the drug Rituximab for those with ME/CFS. How it acts to aid those with immune system disorders and the need for further study of this family of drugs.